{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:15:36Z","timestamp":1793898936722,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03224-x","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:39:20Z","timestamp":1780627160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of 14 triglyceride-glucose (TyG)-related indices with new-onset cardiovascular disease in middle-aged and older adults: evidence from the CHARLS and ELSA aging cohorts"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhang-le","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-fen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"25","key":"3224_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Global Burden of Cardiovascular Diseases Writing Group, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"3224_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew ROE, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the american heart association. Circulation. 2023;148(20):1636\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000001186.","journal-title":"Circulation"},{"key":"3224_CR3","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. https:\/\/doi.org\/10.1016\/j.metabol.2021.154766.","journal-title":"Metabolism"},{"issue":"4","key":"3224_CR4","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133\u2013223. https:\/\/doi.org\/10.1152\/physrev.00063.2017.","journal-title":"Physiol Rev"},{"issue":"1","key":"3224_CR5","doi-asserted-by":"publisher","first-page":"e000911","DOI":"10.1136\/bmjdrc-2019-000911","volume":"7","author":"TV Fiorentino","year":"2019","unstructured":"Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Sesti G. Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage. BMJ Open Diabetes Res Care. 2019;7(1):e000911. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000911.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"3224_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12916-020-01824-2","volume":"18","author":"S Hong","year":"2020","unstructured":"Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18(1):361. https:\/\/doi.org\/10.1186\/s12916-020-01824-2.","journal-title":"BMC Med"},{"key":"3224_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2024.08.026","volume":"131","author":"Y Sun","year":"2025","unstructured":"Sun Y, Ji H, Sun W, An X, Lian F. Triglyceride glucose (TyG) index: a promising biomarker for diagnosis and treatment of different diseases. Eur J Intern Med. 2025;131:3\u201314. https:\/\/doi.org\/10.1016\/j.ejim.2024.08.026.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"3224_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, Liu L, Ming Z, Tao X, Li Y. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8. https:\/\/doi.org\/10.1186\/s12933-023-02115-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"21","key":"3224_CR9","doi-asserted-by":"publisher","first-page":"e042467","DOI":"10.1161\/JAHA.125.042467","volume":"14","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Guo C, Hu X, Li Y, Han S, Liu X, Li P, Zhu H, Liu Z, Guo J. Association of non-insulin-based insulin resistance indices with risk of incident valvular heart disease: results from the UK biobank cohort study. J Am Heart Assoc. 2025;14(21):e042467. https:\/\/doi.org\/10.1161\/JAHA.125.042467.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3224_CR10","doi-asserted-by":"publisher","first-page":"24573","DOI":"10.1038\/s41598-025-08580-4","volume":"15","author":"M Liu","year":"2025","unstructured":"Liu M, Pei J, Zeng C, Xin Y, Tang P, Hu X. Association and predictive value of the triglyceride glucose-weight adjusted waist index for cardiovascular outcomes in patients with type 2 diabetes. Sci Rep. 2025;15(1):24573. https:\/\/doi.org\/10.1038\/s41598-025-08580-4.","journal-title":"Sci Rep"},{"issue":"1","key":"3224_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-025-02662-3","volume":"24","author":"J Hong","year":"2025","unstructured":"Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X. Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):98. https:\/\/doi.org\/10.1186\/s12933-025-02662-3.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3224_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a cohort study. Cardiovasc Diabetol. 2025;24(1):92. https:\/\/doi.org\/10.1186\/s12933-025-02642-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3224_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-023-02100-2","volume":"23","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen X, Shi J, Du M, Li S, Pang J, Qiao J, Zhao Y, Chen Q, Guo Y, Xi Y, Chi W. Relationship between triglyceride-glucose index baselines and trajectories with incident cardiovascular diseases in the elderly population. Cardiovasc Diabetol. 2024;23(1):6. https:\/\/doi.org\/10.1186\/s12933-023-02100-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3224_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12933-024-02457-y","volume":"23","author":"JH Lee","year":"2024","unstructured":"Lee JH, Jeon S, Lee HS, Lee JW. Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis. Cardiovasc Diabetol. 2024;23(1):364. https:\/\/doi.org\/10.1186\/s12933-024-02457-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3224_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-025-02576-0","volume":"24","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tu Z, Liu S, Wang J, Shi J, Li X, Shi R, Chen M, Yue T, Luo S, Ding Y, Zheng X. Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity. Cardiovasc Diabetol. 2025;24(1):33. https:\/\/doi.org\/10.1186\/s12933-025-02576-0. Erratum in: Cardiovasc Diabetol. 2025;24(1):228. doi: 10.1186\/s12933-025-02794-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3224_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12933-026-03077-4","volume":"25","author":"T Jin","year":"2026","unstructured":"Jin T, Tang X, Han Y, Fan H, Qin Q, Jiang H, Chen Z, Li W, Zhu Y, Wu M. Relationship between nine triglyceride-glucose-related indices and cardiometabolic multimorbidity incidence in patients with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2026;25(1):36. https:\/\/doi.org\/10.1186\/s12933-026-03077-4.","journal-title":"Cardiovasc Diabetol"},{"key":"3224_CR17","doi-asserted-by":"publisher","first-page":"111867","DOI":"10.1016\/j.diabres.2024.111867","volume":"217","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu L, Yang P, Li Y, Zhou Y, Yang S, Chen K, Deng S, Zhu X, Liu X, Wang C. Associations of triglyceride-glucose index cumulative exposure and variability with the transitions from normoglycaemia to prediabetes and prediabetes to diabetes: Insights from a cohort study. Diabetes Res Clin Pract. 2024;217:111867. https:\/\/doi.org\/10.1016\/j.diabres.2024.111867.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"3224_CR18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.rec.2025.03.006","volume":"78","author":"M Lin","year":"2025","unstructured":"Lin M, Chen X, Wu M, Xiao J, Li S, Tang H, Tan X, Chen Y. Interactive effects of abdominal obesity and insulin resistance on cardiometabolic risk. Rev Esp Cardiol (Engl Ed). 2025;78(11):967\u201376. https:\/\/doi.org\/10.1016\/j.rec.2025.03.006. English, Spanish.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"1","key":"3224_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12933-024-02122-4","volume":"23","author":"RR Huo","year":"2024","unstructured":"Huo RR, Liao Q, Zhai L, You XM, Zuo YL. Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):30. https:\/\/doi.org\/10.1186\/s12933-024-02122-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3224_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.14797\/mdcvj.1528","volume":"21","author":"I Shahid","year":"2025","unstructured":"Shahid I, Zakaria F, Chang R, Javed U, Amin ZM, Al-Kindi S, et al. Obesity and atherosclerotic cardiovascular disease: a review of social and biobehavioral pathways. Methodist Debakey Cardiovasc J. 2025;21(2):23\u201334. https:\/\/doi.org\/10.14797\/mdcvj.1528.","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"1","key":"3224_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-024-02569-5","volume":"24","author":"R Zhang","year":"2025","unstructured":"Zhang R, Hong J, Wu Y, Lin L, Chen S, Xiao Y. Joint association of triglyceride glucose index (TyG) and a body shape index (ABSI) with stroke incidence: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):7. https:\/\/doi.org\/10.1186\/s12933-024-02569-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3224_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12944-025-02836-8","volume":"25","author":"F Zhang","year":"2025","unstructured":"Zhang F, Zhang B, Huang X, Wang Z, Wang J, Lan H, Xie G, Wang W, Zou Y, Wang C. Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity? Lipids Health Dis. 2025;25(1):33. https:\/\/doi.org\/10.1186\/s12944-025-02836-8.","journal-title":"Lipids Health Dis"},{"key":"3224_CR23","doi-asserted-by":"publisher","unstructured":"Gu M, Hu H, Gu D. Comprehensive evaluation of the triglyceride glucose index (TyG) and body roundness index (BRI) on cardiovascular disease risk prediction: a 9-year prospective cohort study in Chinese middle-aged and older adults. Cardiovasc Diabetol. 2026 Apr;24. https:\/\/doi.org\/10.1186\/s12933-026-03092-5.","DOI":"10.1186\/s12933-026-03092-5"},{"issue":"4","key":"3224_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s13167-024-00380-6","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang M, Guan Q, Guo Z, Guan C, Jin X, Dong H, Tang S, Hou H. Changes in the triglyceride-glucose-body mass index estimate the risk of hypertension among the middle-aged and older population: a prospective nationwide cohort study in China in the framework of predictive, preventive, and personalized medicine. EPMA J. 2024;15(4):611\u201327. https:\/\/doi.org\/10.1007\/s13167-024-00380-6.","journal-title":"EPMA J"},{"key":"3224_CR25","doi-asserted-by":"publisher","unstructured":"Liu H, Guo F, Fu H, Xu X, Wang Z, Kang J, Feng J, Shen Y, Liu W. Associations of triglyceride-glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis. Cardiovasc Diabetol. 2026 Mar;26. https:\/\/doi.org\/10.1186\/s12933-026-03148-6.","DOI":"10.1186\/s12933-026-03148-6"},{"key":"3224_CR26","doi-asserted-by":"publisher","first-page":"1148203","DOI":"10.3389\/fendo.2023.1148203","volume":"14","author":"W Xu","year":"2023","unstructured":"Xu W, Zhao H, Gao L, Guo L, Liu J, Li H, Sun J, Xing A, Chen S, Wu S, Wu Y. Association of long-term triglyceride-glucose index level and change with the risk of cardiometabolic diseases. Front Endocrinol (Lausanne). 2023;14:1148203. https:\/\/doi.org\/10.3389\/fendo.2023.1148203.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3224_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12933-024-02281-4","volume":"23","author":"X Zhu","year":"2024","unstructured":"Zhu X, Xu W, Song T, Wang X, Wang Q, Li J, Liu X, Hao B, Chen T, Guo J. Changes in the combination of the triglyceride-glucose index and obesity indicators estimate the risk of cardiovascular disease. Cardiovasc Diabetol. 2024;23(1):192. https:\/\/doi.org\/10.1186\/s12933-024-02281-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3224_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12933-025-02657-0","volume":"24","author":"J Xu","year":"2025","unstructured":"Xu J, Cai D, Jiao Y, Liao Y, Shen Y, Shen Y, Han W. Insights into the complex relationship between triglyceride glucose-waist height ratio index, mean arterial pressure, and cardiovascular disease: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):93. https:\/\/doi.org\/10.1186\/s12933-025-02657-0. Erratum in: Cardiovasc Diabetol. 2025;24(1):214. doi: 10.1186\/s12933-025-02728-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3224_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12933-024-02510-w","volume":"23","author":"X Tian","year":"2024","unstructured":"Tian X, Chen S, Xia X, Xu Q, Zhang Y, Zheng C, Wu S, Wang A. Pathways from insulin resistance to incident cardiovascular disease: a Bayesian network analysis. Cardiovasc Diabetol. 2024;23(1):421. https:\/\/doi.org\/10.1186\/s12933-024-02510-w.","journal-title":"Cardiovasc Diabetol"},{"key":"3224_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/978-3-031-63657-8_17","volume":"1460","author":"A Engin","year":"2024","unstructured":"Engin A. Endothelial dysfunction in obesity and therapeutic targets. Adv Exp Med Biol. 2024;1460:489\u2013538. https:\/\/doi.org\/10.1007\/978-3-031-63657-8_17.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"3224_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-024-02571-x","volume":"24","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhou Y, Xu Y, Wang X, Zhou Z, Wu K, Meng Q, Wang L, Yang Y, Gao H, Ji J, Jiang X, Yang Y, Hao L, Wang H. Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts. Cardiovasc Diabetol. 2025;24(1):11. https:\/\/doi.org\/10.1186\/s12933-024-02571-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"20","key":"3224_CR32","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.jacc.2025.08","volume":"86","author":"MS Khan","year":"2025","unstructured":"Khan MS, Javaid SS, Dinani A, Wegermann K, Pandey A, Bhatt AS, Muthiah M, Van Spall HGC, Zannad F, Butler J, Volk ML, Fudim M. The basics of metabolic dysfunction-associated steatotic liver disease for cardiologists: pathophysiology, diagnosis, and treatment. J Am Coll Cardiol. 2025;86(20):1861\u201384. https:\/\/doi.org\/10.1016\/j.jacc.2025.08.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3224_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41574-024-01047-y","volume":"21","author":"M Sot\u00e1k","year":"2025","unstructured":"Sot\u00e1k M, Clark M, Suur BE, B\u00f6rgeson E. Inflammation and resolution in obesity. Nat Rev Endocrinol. 2025;21(1):45\u201361. Epub 2024 Oct 24. https:\/\/doi.org\/10.1038\/s41574-024-01047-y","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"3224_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","volume":"24","author":"Y Sun","year":"2025","unstructured":"Sun Y, Guo Y, Ma S, Mao Z, Meng D, Xuan K, Lu R, Pan X, Zhu X. Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):313. https:\/\/doi.org\/10.1186\/s12933-025-02835-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3224_CR35","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1097\/JS9.0000000000003560","volume":"112","author":"G Song","year":"2026","unstructured":"Song G. The C-reactive protein-triglyceride glucose index (CTI) predicts mortality in cardiovascular-kidney-metabolic syndrome: a dual-cohort study with machine learning validation. Int J Surg. 2026;112(1):1340\u201352. https:\/\/doi.org\/10.1097\/JS9.0000000000003560.","journal-title":"Int J Surg"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03224-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:02:55Z","timestamp":1786446175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03224-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3224"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03224-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Both studies were conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval was obtained from the respective institutional review boards: Peking University\u2019s Institutional Review Board provided approval for CHARLS(IRB 00001052\u201311015); ELSA was jointly approved by the Research Ethics Committee of University College London and the research ethics committees of all participating regions. Written informed consent was obtained from all individual participants included in the studies.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"225"}}